###begin article-title 0
Aging Reveals a Role for Nigral Tyrosine Hydroxylase ser31 Phosphorylation in Locomotor Activity Generation
###end article-title 0
###begin p 1
Conceived and designed the experiments: MFS. Performed the experiments: MFS SLS. Analyzed the data: MFS SLS CD. Contributed reagents/materials/analysis tools: MFS CD. Wrote the paper: MFS BSP. Assisted with revisions and conceptual argument development: BSP.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 380 387 380 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Tyrosine hydroxylase (TH) regulates dopamine (DA) bioavailability. Its product, L-DOPA, is an established treatment for Parkinson's disease (PD), suggesting that TH regulation influences locomotion. Site-specific phosphorylation of TH at ser31 and ser40 regulates activity. No direct evidence shows that ser40 phosphorylation is the dominating mechanism of regulating TH activity in vivo, and physiologically-relevant stimuli increase L-DOPA biosynthesis independent of ser40 phosphorylation. Significant loss of locomotor activity occurs in aging as in PD, despite less loss of striatal DA or TH in aging compared to the loss associated with symptomatic PD. However, in the substantia nigra (SN), there is equivalent loss of DA or TH in aging and at the onset of PD symptoms. Growth factors increase locomotor activity in both PD and aging models and increase DA bioavailability and ser31 TH phosphorylation in SN, suggesting that ser31 TH phosphorylation status in the SN, not striatum, regulates DA bioavailability necessary for locomotor activity.
###end p 3
###begin title 4
Methodology and Principal Findings
###end title 4
###begin p 5
###xml 96 97 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 105 109 <span type="species:ncbi:10116">rats</span>
We longitudinally characterized locomotor activity in young and older Brown-Norway Fischer 344 F1 hybrid rats (18 months apart in age) at two time periods, eight months apart. The aged group served as an intact and pharmacologically-naive source of deficient locomotor activity. Following locomotor testing, we analyzed DA tissue content, TH protein, and TH phosphorylation in striatum, SN, nucleus accumbens, and VTA. Levels of TH protein combined with ser31 phosphorylation alone reflected inherent differences in DA levels among the four regions. Measures strictly pertaining to locomotor activity initiation significantly correlated to DA content only in the SN. Nigral TH protein and ser31 phosphorylation together significantly correlated to test subject's maximum movement number, horizontal activity, and duration.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Together, these results show ser31 TH phosphorylation regulates DA bioavailability in intact neuropil, its status in the SN may regulate locomotor activity generation, and it may represent an accurate target for treating locomotor deficiency. They also show that neurotransmitter regulation in cell body regions can mediate behavioral outcomes and that ser31 TH phosphorylation plays a role in behaviors dependent upon catecholamines, such as dopamine.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 148 151 148 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Bennet1">[1]</xref>
###xml 153 156 153 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Prettyman1">[2]</xref>
###xml 556 559 556 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Prettyman1">[2]</xref>
###xml 560 563 560 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Buchman1">[5]</xref>
###xml 679 682 679 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Bernheimer1">[6]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Bezard1">[10]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Kish1">[11]</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Haycock1">[15]</xref>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Haycock1">[15]</xref>
###xml 1004 1008 1004 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-McCormack1">[20]</xref>
###xml 1076 1079 1076 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Bernheimer1">[6]</xref>
###xml 1081 1084 1081 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Hornykiewicz1">[8]</xref>
###xml 706 712 <span type="species:ncbi:9606">humans</span>
We face an increased probability of reduced mobility (bradykinesia) with advancing age, with a 50% risk of this Parkinsonian-like symptom by age 85 [1], [2]. The neurobiological basis of this aging-related impairment to locomotion is crucial to resolve, particularly due to the imminent increase of the elderly population. Aging-related Parkinsonism presents symptoms similar to Parkinson's disease (PD) and, like PD, they are progressive, impair performance of essential locomotor functions, and increase risk of cognitive impairment, dementia, and death [2]-[5]. Major dopamine (DA) loss of 70-80% in the striatum is thought to be required for major symptom presentation in PD [6]-[10]. However, in aged humans and animal models alike, striatal DA loss does not reach symptomatic levels seen in PD, ranging instead from 0 to 50% [11]-[15]. Throughout the lifespan there is also little if any aging-related loss of striatal tyrosine hydroxylase ((TH), the rate-limiting enzyme for DA biosynthesis) [15]-[20], which is in stark contrast to the 80% loss seen in symptomatic PD [6], [8]. Thus, it is curious why aging-related Parkinsonism occurs if DA and TH loss are not equivalent to the symptomatic levels seen in PD. If TH loss does not occur in striatum during aging, it is possible that either decreased striatal TH activity may contribute to Parkinsonism, or decreased TH protein or activity in another DA region is the source of Parkinsonism.
###end p 9
###begin p 10
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Haycock2">[21]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Haycock3">[22]</xref>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Haycock4">[23]</xref>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Dunkley1">[26]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore3">[27]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Conner1">[28]</xref>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore2">[25]</xref>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Harada1">[29]</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore2">[25]</xref>
The activity of TH is regulated by site-specific phosphorylation, but of the three physiologically-regulated sites in the CNS (ser19, ser31, and ser40) [21], the site most critical for regulating DA biosynthesis in intact neuropil is unknown. Phosphorylation of TH at ser19 does not directly influence TH activity [22], but increased phosphorylation of ser40 can increase TH activity [23]-[26] and is associated with increased DA turnover in neurodegenerative or other CNS disorders [27], [28]. However, a certain threshold of phosphorylation may be required to affect DA biosynthesis [25] and ser40 phosphorylation is not required for stimulation of L-DOPA biosynthesis by depolarizing stimuli [29]. However, increases in ser31 phosphorylation alone increase L-DOPA biosynthesis [25]. Understanding the extent to which ser31 or ser40 phosphorylation modulate DA bioavailability in intact neuropil is necessary to define the molecular basis for DA-dependent behaviors, such as locomotion.
###end p 10
###begin p 11
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Parkinson1">[30]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Palmiter1">[31]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Huang1">[32]</xref>
###xml 669 673 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Beeler1">[33]</xref>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Cheramy1">[34]</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Fortin1">[35]</xref>
###xml 864 868 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Hebert1">[12]</xref>
###xml 870 874 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Yurek1">[13]</xref>
###xml 929 933 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Hoffman1">[36]</xref>
###xml 935 939 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Rice1">[37]</xref>
###xml 1040 1044 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Emborg1">[38]</xref>
###xml 1189 1193 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Andersson1">[39]</xref>
###xml 1232 1236 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Robertson1">[40]</xref>
###xml 1238 1242 1226 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Trevitt1">[41]</xref>
###xml 1434 1438 1422 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Bezard1">[10]</xref>
###xml 1440 1444 1428 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Fearnley1">[42]</xref>
###xml 1458 1462 1446 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-1">[18]</xref>
###xml 1464 1468 1452 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Emborg1">[38]</xref>
###xml 1470 1474 1458 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Sanchez1">[43]</xref>
###xml 1615 1619 1603 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Ponzio1">[44]</xref>
###xml 1662 1666 1650 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Rudow1">[45]</xref>
###xml 1687 1691 1675 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Irwin1">[17]</xref>
###xml 1701 1705 1689 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Yurek1">[13]</xref>
###xml 1656 1661 <span type="species:ncbi:9606">human</span>
###xml 1672 1677 <span type="species:ncbi:9606">human</span>
###xml 1697 1700 <span type="species:ncbi:10116">rat</span>
While loss of TH activity may explain variable DA loss in the aged striatum, it is also possible that aging reduces TH protein or activity, and therefore DA bioavailability, in other regions affecting locomotor activity. For example DA signaling in the nucleus accumbens (NAc) affects goal-related locomotor activity [30] as it does in striatum [31]. However, stimulant-induced increases in DA signaling in NAc are similar between aged and young subjects and thus do not explain reduced stimulant-induced locomotion in aged subjects [32]. A potential explaination is that an intact nigrostriatal pathway may be necessary for stimulant enhancement of locomotor activity [33]. In this pathway, dopamine is released not only in striatum, but also in the substantia nigra (SN) [34], [35]. Although striatal DA tissue content is approximately10-fold greater than in SN [12], [13], DA in SN has a longer synaptic life than in striatum [36], [37]. Notably, unlike striatum, aging reduces TH protein in SN and this correlates with motor impairment [38]. Thus TH regulation of DA in the SN may affect certain aspects of locomotor activity generation. In fact, decreasing nigral DA release capacity [39] or blocking its post-synaptic actions [40], [41] reduces locomotor activity. Bradykinesia is a common symptom of PD and aging. Similar deficiencies in nigral DA signaling as well as reduced TH protein reported with the onset of PD symptoms [10], [42] and in aging [18], [38], [43] also point to the possibility that nigral DA bioavailability regulates locomotor activity generation. Aging also reduces nigral TH activity [44], and DA loss ranges from 36%-70% in human [45], non-human primates [17], and rat [13]. Thus, deficits in TH protein and phosphorylation at the key TH activity-modulating site in SN could be the common source of bradykinesia in PD and in aging.
###end p 11
###begin p 12
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Hoffer1">[46]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Grondin1">[49]</xref>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore4">[50]</xref>
###xml 668 672 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore5">[51]</xref>
###xml 797 801 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Slevin1">[52]</xref>
###xml 283 287 <span type="species:ncbi:10116">rats</span>
###xml 697 702 <span type="species:ncbi:9606">human</span>
###xml 788 796 <span type="species:ncbi:9606">patients</span>
###xml 1117 1121 <span type="species:ncbi:10116">rats</span>
Studies with growth factors indicate that nigral TH activity may regulate locomotor activity. GDNF increases locomotor activity in both aging or PD models in conjunction with increased nigral DA tissue content, notably without affecting striatal DA tissue content [46]-[49]. In aged rats, GDNF produces a large increase in ser31 phosphorylation in the SN [50], suggesting that the action of GDNF is to reverse possible aging-related reductions in nigral ser31 phosphorylation, thereby increasing nigral DA and locomotor activity as reported. Furthermore, unilateral striatal GDNF administration increases TH phosphorylation bilaterally only in the SN and not striatum [51]. This may also occur in human, as bilateral motor improvement is reported following unilateral GDNF delivery in PD patients [52]. Taken together, we hypothesized that ser31 phosphorylation of TH in SN may regulate DA bioavailability necessary for particular aspects of locomotor activity. To test this hypothesis we profiled DA tissue content and TH protein and phosphorylation in the nigrostriatal and mesoaccumbens pathways in young and aged rats following longitudinal characterization of inherent locomotor activity. This design, while correlational, provided an intact and pharmacologically-naive source of potential endogenous differences in DA bioavailability in DA neuropil in two groups significantly different in locomotor activity to address which TH phosphorylation site normally regulates DA bioavailability and which DA region influences specific aspects of inherent locomotor activity.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
2.1 Test Subject Selection and Handling
###end title 14
###begin p 15
###xml 193 194 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 296 306 296 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 814 818 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Yurek1">[13]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Spangler1">[53]</xref>
###xml 1060 1064 1060 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-CruzMuros1">[54]</xref>
###xml 1357 1361 1357 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Hebert1">[12]</xref>
###xml 1377 1378 1377 1378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1499 1503 1499 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Phelan1">[55]</xref>
###xml 1536 1537 1536 1537 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1592 1596 1592 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Sprott1">[56]</xref>
###xml 14 18 <span type="species:ncbi:10116">rats</span>
###xml 208 212 <span type="species:ncbi:10116">rats</span>
###xml 886 889 <span type="species:ncbi:10116">rat</span>
###xml 986 1005 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 1285 1290 <span type="species:ncbi:9606">human</span>
###xml 1299 1304 <span type="species:ncbi:9606">human</span>
Young and old rats were chosen for this study because differences in locomotor activity are derived from intact and pharmacologically-naive neuropil. Two age groups of Brown-Norway Fisher 344 F1 hybrid (BNF) rats arrived at the medical center at one and 19 months of age and given food and water ad libitum for three months prior to the start of any locomotor assessment. All locomotor testing was done between the hours of 0900 and 1700. All animals used in this study were drug naive and other than being tested for locomotor activity 17 times for one hour each session, remained in their home cage, singly housed. The BNF strain was selected for this study because aging-related changes in striatal and midbrain DA tissue content are comparable to that in the primates and exhibits reduced locomotion in aging ([13], [53], and as discussed in main text), making it arguably the best rat model to address the relative role of the striatal and nigral DA in locomotor activity. Outbred Sprague-Dawley rats also show DA loss in the midbrain like the BNF strain [54] but may have increased variance in a variety of measures. The inbred Fischer 344, a commonly used strain in aging studies, does not show any significant tissue loss of DA in striatum or midbrain, contrary to findings in human and non-human primates (although release of DA is compromised 50% [12]). In general, F1 hybrids have less variability in a large number of physiological and behavioral measures, including locomotor functions [55]. This reduction in variance in F1 hybrids requires fewer animals to attain significance [56].
###end p 15
###begin title 16
2.2 Assessment of Locomotor Activity
###end title 16
###begin p 17
###xml 747 748 747 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 347 350 <span type="species:ncbi:10116">rat</span>
###xml 1440 1443 <span type="species:ncbi:10116">rat</span>
###xml 1571 1574 <span type="species:ncbi:10116">rat</span>
Open-field locomotor activity was determined a total of 17 times in two specific time points, the young being tested at 4-5 months and again eight months later at 11-12 months, and the older group at 22-23 months of age and again eight months later at 29-30 months of age. [Neurochemical measures were made only at the 12 and 30 month ages]. Each rat was tested by pairing with the same different age counterpart in separate locomotor test chambers (10 trials in the first period of life and 7 trials in the second period of life eight months later). Spontaneous locomotor activity was assessed in 1 hour duration trials using automated activity chambers (VersaMax Animal Activity Monitoring System, Columbus, OH), which consisted of a 41x41x31 cm3 plexiglass box with a grid of infrared beams mounted horizontally every 2.5 cm and vertically every 4.5 cm. The beams are generated from monitors connected to a VersaMax analyzer which transmits the number of beam breaks (locomotor activity) to a dedicated computer with VersaMax software to collect and analyze the locomotor measures. Activity data was recorded in four consecutive 15 min samples and the sum total for movement number, total distance (cm), horizontal activity (unitless measure of all horizontal activity), time spent moving (sec) were recorded. Movement speed was calculated by dividing total distance by time spent moving (cm/sec). The typical life-expectancy of the BNF rat is approximately 32 months and thus, the locomotor activities in about one-fourth to one-third of the average life span of the rat were determined for each age group. Combining both operationally-matched age groups, the locomotor activity patterns of virtually the entire adult life span was determined.
###end p 17
###begin p 18
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore6">[57]</xref>
###xml 134 138 <span type="species:ncbi:10116">rats</span>
To assess DA tissue content and TH protein and phosphorylation, within 5-10 min following the last (17th) locomotor test session, the rats were killed in alternating order of young or old, and dorsal striatum, substantia nigra, nucleus accumbens, and VTA were dissected from 1 mm coronal slices as previously described [57] and stored on dry ice and -70degreesC until processed for DA analysis by HPLC, protein levels, and phosphorylation analysis by western blotting.
###end p 18
###begin title 19
2.3 Neurochemistry: Dopamine Analysis
###end title 19
###begin p 20
###xml 1011 1015 1011 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore3">[27]</xref>
The analysis of DA tissue content from striatum, SN, NAc, and VTA allowed for two major objectives to be addressed; 1) to determine how TH phosphorylation controls DA biosynthesis capacity in the CNS, and 2) to correlate to measures of locomotor activity with DA tissue content in these four regions. Given the well-established DA hypothesis for locomotion, this experimental design makes it possible to determine whether DA in one or more of these regions influenced locomotion. Our operationally-matched assessment of DA tissue content and TH measures from all four brain regions from each test subject is a novel state-of-the-art approach to equate the DA tissue content resulting from a respective TH protein and TH phosphorylation profile and to determine their contributions to locomotor activity. This addition of locomotor measures to the neurochemical profile is the first known study of its kind, which adds a behavioral component in assessing DA tissue content with TH protein and TH phosphorylation [27].
###end p 20
###begin p 21
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Lavicky1">[58]</xref>
Tissues were sonicated in ice-cold 0.1 M HClO4-EDTA buffer. Aliquots from these protein-precipitated supernatants were analyzed for content of DA by HPLC [58]. Determination of DA is calculated based upon percent recovery of the internal standard (N-methyl-dopamine (NMDA), 20 ng/mL) in each sample, the peak height ratios obtained for both DA and NMDA in a standard and in the sample, and the fraction of the aliquot analyzed by HPLC representing the total volume of the sonicated tissue. The acid buffer treatment for HPLC analysis precipitates the protein content inherent in the sample, and this protein pellet was sonicated in 1% SDS with 5 mM Tris buffer (pH 8.3) and 1 mM EDTA to determine total protein, TH protein, and site-specific TH phosphorylation.
###end p 21
###begin p 22
###xml 552 559 552 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">Table 1</xref>
We normalized total DA to protein, as opposed to the wet weight of tissue. This was done to control for variances that can arise from contributions of non-protein material. However, this normalization also requires precision dissections for each test subject along the rostral-caudal axis, as the inadvertent additions of non-DA cells in the dissection would increase protein content not related to DA neuropil. For this reason, we present the DA measures as per total DA harvested and as total DA normalized to mg protein. These results were similar (Table 1) and had significant correlation with each other (data not shown). Furthermore, our additional normalization of total DA to total TH harvested in the sample is the strictest normalization to DA neuropil and gives the best insight into endogenous TH activity.
###end p 22
###begin title 23
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p-values of locomotor functions versus DA tissue content.
###end title 23
###begin p 24
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 283 291 283 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lifetime</italic>
###xml 425 434 425 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">session 2</italic>
###xml 509 536 509 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">highest and lowest lifetime</italic>
###xml 622 632 622 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">last trial</italic>
###xml 227 231 <span type="species:ncbi:10116">rats</span>
Correlation statistics (p-values derived from Spearman correlation) of locomotor activity measures to respective DA tissue content (total ng or total ng per protein) in striatum and SN analyzed in 7 paired 12- and 30-month old rats. Activity measures are further subdivided into the lifetime average (mean of 17 total locomotor trials conducted at 4 and 12 months for the young group and 22 and 30 months for the old group), session 2 (mean of seven locomotor trials that were conducted at 12 and 30 months), highest and lowest lifetime (highest ever, and lowest ever, locomotor activity measures of the 17 sessions), and last trial (the final locomotor activity measure of the 17, recorded immediately prior to tissue dissection). Significant correlations are in bold.
###end p 24
###begin title 25
2.4 Neurochemistry: Determination of TH Protein and Phosphorylation
###end title 25
###begin p 26
###xml 583 586 583 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 1015 1019 1015 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore2">[25]</xref>
###xml 1021 1025 1021 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore3">[27]</xref>
###xml 1027 1031 1027 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore4">[50]</xref>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore5">[51]</xref>
###xml 1039 1043 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore6">[57]</xref>
Protein levels were determined by BCA method and samples were prepared in reducing (dithiothreitol used as reducing agent) sample buffer containing SDS and subjected to SDS gel electrophoresis on 10% gels, and transferred to nitrocellulose. Protein loads were verified by Ponceau S stain and blots were preincubated with polyvinylpyrrolidone-based Tris buffer for at least 2 hr prior to antibody exposure to reduce non-specific binding. For each blot immunolabeling experiment, after treatment with primary and secondary antibody (for signal enhancement), the detection method used I125-protein A (high-specific activity). The blots were exposed to Kodak film which reveals immunoreactive areas on the blot. These areas were excised and counted for gamma radioactivity. To quantify total TH, in house standards (calibrated PC12 cell extract) are used to interpolate sample immunoreactivity to anti-TH versus a standard curve of known quantities of TH and the value is expressed as ng TH per ug total protein loaded [25], [27], [50], [51], [57].
###end p 26
###begin p 27
###xml 203 205 203 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 378 385 378 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s002">Fig. S1</xref>
###xml 387 394 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s001">Text S1</xref>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore2">[25]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore3">[27]</xref>
###xml 621 625 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore4">[50]</xref>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore5">[51]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore6">[57]</xref>
Protein phosphorylation is quantified by western blot using affinity-purified primary antibodies specific to each phosphorylation site. We used our own affinity-purified ser31 phosphorylation primary (21st Century Biochemicals), and ser19 and ser40 antibodies were a gift from Dr. John W. Haycock. The ser31 primary antibody was validated for phosphorylation-state specificity (Fig. S1, Text S1). Calibrated phosphorylation site-specific in house standards are used to quantify phosphorylation levels and are normalized to the TH content to determine the phosphorylation stoichiometry, as previously reported [25], [27], [50], [51], [57]. Assays for TH protein and its site-specific phosphorylation are conducted within the dynamic working range of each antibody.
###end p 27
###begin title 28
2.5 Statistics
###end title 28
###begin title 29
Analysis of locomotor profiles
###end title 29
###begin p 30
###xml 667 674 667 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">table 1</xref>
###xml 911 913 911 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
Locomotor activity was analyzed in five parameters. Four parameters (movement number, total distance, horizontal activity, and time spent moving) were recorded with software as previously described and movement speed was calculated as total distance divided by time spent moving. Aging related comparisons were analyzed by ANOVA followed by Bonferroni's multiple comparison test between the age groups and also a Student's t-test was used for within age-group comparisons (4 vs. 12 months, 22 vs. 30 months). Correlations between dependent measures used the Spearman correlation coefficient, including correlations of locomotor activity with DA measures, as shown in table 1. The five parameters of locomotor activity for each test subject were also analyzed in five ways (lifetime average, average of second session of seven trials, highest lifetime trial result, lowest lifetime trial result, and the last (17th) trial.
###end p 30
###begin title 31
Analysis of neurochemical profiles
###end title 31
###begin p 32
Dopamine tissue content was analyzed three ways; 1) total DA recovered per region, 2) total DA recovered per total protein, 3) total DA recovered per total TH. The respective tissue content of DA in the four regions are considered treatments for the purpose of determining the influence of TH protein and site-specific phosphorylation upon DA tissue content. The role of site-specific phosphorylation upon DA tissue content was determined by normalizing inherent DA to TH protein and comparing differences in site-specific phosphorylation to the differences in DA per TH protein in each region (ANOVA followed by Bonferroni's multiple comparison test). We also compared total DA harvested in each region with total TH protein harvested to show how TH protein alone contributes but does not fully account for the regional differences in DA.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
3.1 Molecular Origin of DA Bioavailability
###end title 34
###begin p 35
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore2">[25]</xref>
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Dunkley1">[26]</xref>
###xml 240 247 240 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 339 340 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 347 354 347 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s003">Fig. S2</xref>
###xml 520 527 520 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1a</xref>
###xml 578 585 578 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1b</xref>
###xml 901 908 901 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1c</xref>
###xml 970 977 970 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1173 1180 1173 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1d</xref>
###xml 1254 1261 1254 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1e</xref>
###xml 1274 1281 1274 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1f</xref>
Although phosphorylation of TH by ERK at ser31 or PKA at ser40 can increase DA biosynthesis in situ[25], [26], which phosphorylation site affects DA bioavailability in intact neuropil is unknown. As would be predicted, though not yet shown in vivo, total TH protein content in the SN correlated to total DA recovered in each test subject (p<0.05, Fig. S2) and significant correlations were also seen in the other three regions (data not shown). However, relative differences in DA tissue content among the four regions (Fig. 1a) were not matched by TH content in these tissues (Fig. 1b) [note that actual values are indicated in figure legend to support this finding], signifying that site-specific phosphorylation also contributes to regulating inherent DA tissue content in the CNS. Normalizing DA tissue content to total TH recovered in each region removes the influence of total TH on DA content (Fig. 1c). Therefore, the phosphorylation site regulating TH activity in vivo in intact neuropil would be predicted to vary across all four regions in a pattern similar to the differences in TH-normalized DA content. The differences in ser31 phosphorylation stoichiometry (Fig. 1d) reflected these differences in TH-normalized DA content, whereas ser40 (Fig. 1e) and ser19 (Fig. 1f) phosphorylation stoichiometry did not reflect these differences.
###end p 35
###begin title 36
Dopamine, tyrosine hydroxylase protein, and phosphorylation stoichiometry (ps) comparisons in nigrostriatal and mesoaccumbens pathways.
###end title 36
###begin p 37
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 204 224 204 224 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a. total DA recovery</bold>
###xml 344 372 336 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b. total TH protein recovery</bold>
###xml 463 497 447 481 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c. TH-Normalized DA tissue content</bold>
###xml 688 689 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 711 712 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 732 733 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 759 760 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 769 812 745 788 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d. ser31 phosphorylation stoichiometry (PS)</bold>
###xml 1005 1006 973 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1028 1029 996 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1050 1051 1018 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1077 1078 1045 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1087 1098 1055 1066 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e. ser40 PS</bold>
###xml 1299 1300 1259 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1322 1323 1282 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1345 1346 1305 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1371 1372 1331 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1380 1391 1340 1351 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f. ser19 PS</bold>
###xml 1584 1585 1536 1537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1607 1608 1559 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1629 1630 1581 1582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1651 1652 1603 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1677 1678 1629 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 176 180 <span type="species:ncbi:10116">rats</span>
Analyses of striatum (str), substantia nigra (SN), nucleus accumbens (NAc), and ventral tegmental area (VTA) from all test subjects (n = 14, seven pairs of 12 and 30 month old rats from locomotor study). a. total DA recovery The mean relative total recovery of DA (in ng) was Str = 214+/-16; SN = 8.4+/-0.8; NAc =  59.6+/-5.8; VTA = 6.0+/-1.0. b. total TH protein recovery The mean TH recovery (in ng) was Str = 473+/-49; SN = 59+/-9; NAc = 68+/-9; VTA = 26+/-5. c. TH-Normalized DA tissue content Str 0.56+/-0.11, SN 0.18+/-0.03, NAc 0.77+/-0.03, VTA 0.22+/-0.03. There was a significant difference in DA recovered per TH among the four regions (ANOVA (p<0.0001) and between Str and SN (p<0.001), Str and VTA (p<0.01), SN and NAc (p<0.001), and VTA and NAc (p<0.001). d. ser31 phosphorylation stoichiometry (PS) Str 0.33+/-0.02, SN 0.09+/-0.01, NAc 0.36+/-0.01, VTA 0.10+/-0.01. There was a significant difference in ser31 phosphorylation among the four regions (ANOVA (p<0.0001) and between Str and SN (p<0.001), Str and VTA (p<0.001), SN and NAc (p<0.001), and VTA and NAc (p<0.001). e. ser40 PS Str 0.022+/-0.001, SN 0.045+/-0.004, NAc 0.049+/-0.004, VTA 0.035+/-0.002. There was a significant difference in ser40 phosphorylation among the four regions (ANOVA (p<0.0001) and between Str and SN (p<0.001), Str and NAc (p<0.001), Str and VTA (p<0.05), and NAc and VTA (p<0.05). f. ser19 PS Str 0.06+/-0.01, SN 0.13+/-0.01, NAc 0.12+/-0.01, VTA 0.25+/-0.01. There was a significant difference in ser19 phosphorylation among the four regions (ANOVA (p<0.0001) and between Str and SN (p<0.001), Str and NAc (p<0.01), Str and VTA (p<0.001), SN and VTA (p<0.001) and NAc and VTA (p<0.001).
###end p 37
###begin p 38
###xml 288 295 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1a</xref>
###xml 366 373 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1a</xref>
###xml 484 491 472 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1b</xref>
###xml 600 607 576 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1d</xref>
###xml 636 637 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 645 652 621 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1d</xref>
###xml 765 777 741 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Figs. 1e, 1f</xref>
###xml 857 864 833 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1a</xref>
###xml 934 941 910 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1d</xref>
###xml 1056 1063 1032 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1b</xref>
Total TH protein also affected total DA content in conjunction with ser31 phosphorylation. Total DA recovered from the four tissues was greatest in the striatum, followed by the nucleus accumbens ((NAc) approximately3.5-fold less than striatum), and comparable amounts in the SN and VTA (Fig. 1a). Recovery of DA in the NAc was nearly seven-fold greater than in SN (Fig. 1a) despite relatively equal recovery of TH protein between the NAc and SN (68 and 59 ng total TH, respectively (Fig. 1b)), and this difference was explained by approximatelyfour-fold greater ser31 phosphorylation stoichiometry (Fig. 1d) in the NAc compared to SN (p<0.001, Fig. 1d), whereas ser19 or ser40 phosphorylation stoichiometry was not significantly different between the two regions (Figs. 1e, 1f). However, total DA recovery in striatum was 3.5-fold greater than in the NAc (Fig. 1a), in spite of similar levels of ser31 phosphorylation stoichiometry (Fig. 1d). Between these regions it appears that the 3- to 4-fold greater level of TH protein in striatum compared to NAc (Fig. 1b) influenced their inherent differences in DA.
###end p 38
###begin p 39
###xml 504 511 504 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g002">Fig. 2a</xref>
###xml 537 548 537 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g002">Fig. 2b, 2c</xref>
###xml 637 644 637 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1a</xref>
###xml 758 765 758 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1a</xref>
###xml 877 884 877 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1b</xref>
###xml 948 955 948 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1d</xref>
###xml 997 1004 997 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g002">Fig. 2b</xref>
###xml 1204 1211 1204 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1a</xref>
These data show that both TH protein levels and phosphorylation at ser31 in intact CNS tissue affect DA tissue content. Thus, multiplying the total TH protein content by TH phosphorylation stoichiometry (effective stoichiometry) at the key regulatory phosphorylation site should represent inherent DA biosynthesis capabilities in DA neuropil. The effective stoichiometry at ser31 should, therefore, reflect the differences in DA content across each region. Indeed, the effective stoichiometry for ser31 (Fig. 2a), unlike ser40 or ser19 (Fig. 2b, 2c), had similar region-to-region variance as compared to differences in total DA content (Fig. 1a). Notably, this is apparent in comparing striatum to SN, as there was a 25-fold greater level of DA in striatum (Fig. 1a) and a nearly identical 24-fold difference in effective stoichiometry at ser31 (eight-fold greater TH protein (Fig. 1b) times three-fold greater ser31 phosphorylation stoichiometry (Fig. 1d)). The effective stoichiometry at ser40 (Fig. 2b) was only four-fold different between striatum and SN and was not significantly different between SN and nucleus accumbens and as such did not reflect the differences in DA tissue content recovered (Fig. 1a). These observations clearly show that ser31 phosphorylation, in conjunction with TH protein content, regulates DA bioavailability in the intact nigrostriatal and mesoaccumbens dopaminergic neuropil. In terms of behavioral significance, these findings suggest that ser31 phosphorylation status may drive DA-dependent behaviors from neuroanatomical loci associated with such behaviors.
###end p 39
###begin title 40
Tyrosine hydroxylase effective stoichiometry in nigrostriatal and mesoaccumbens pathways.
###end title 40
###begin p 41
###xml 118 120 118 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a.</bold>
###xml 120 128 120 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser31 es</bold>
###xml 252 275 252 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b. Ser40 es c. ser19 es</bold>
###xml 467 474 467 474 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1a</bold>
###xml 467 474 467 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001"><bold>Fig. 1a</bold></xref>
Values are obtained by multiplying total inherent TH protein content by phosphorylation stoichiometry in each sample. a.Ser31 es. Stoichiometry determined by anti-phospho ser31 TH against calibrated standards for ser31 and divided by total TH protein. b. Ser40 es c. ser19 es Values were calculated based upon each subject's ps value and multiplied by the mean total TH. Region-to-region difference for ser31 es was similar to the difference in total DA (as shown in Fig. 1a) recovered from the longitudinally-characterized inherent locomotor activity patterns for the test subjects.
###end p 41
###begin title 42
3.2 Locomotor Profiling and Regional Dopamine Bioavailability Correlations
###end title 42
###begin p 43
###xml 914 921 914 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s004">Fig. S3</xref>
###xml 1080 1088 1080 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s007">Table S1</xref>
###xml 82 86 <span type="species:ncbi:10116">rats</span>
Prior to neurochemical analyses, the test subjects, seven young and seven old BNF rats (groups differing in age by 18 months), were characterized for open-field locomotor activity, independent of exogenous influences such as systemically- or CNS-delivered drugs, in a longitudinal study. There were ten trials conducted when the young group was 4 months old and the old group was 22 months old, and another seven trials conducted when the young group was 12 months old and the old group was 30 months old. The paucity of initiated movement is a signature behavioral symptom of bradykinesia, and as such, movement number, horizontal activity, and time spent moving are three locomotor activity measures arguably the closest to quantifying bradykinesia. Notably, movement number had significant correlation with all other measures of locomotor activity at all ages of testing, with the exception of movement speed, (Fig. S3). The repetitive nature of the locomotor activity measures did not produce a significant decrease in locomotor activity in the majority of the test subjects (Table S1) in either testing session, so habituation was not a confounding effect on mean locomotor results.
###end p 43
###begin p 44
###xml 187 195 187 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lifetime</italic>
###xml 329 338 329 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">session 2</italic>
###xml 403 430 403 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">highest and lowest lifetime</italic>
###xml 516 526 516 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">last trial</italic>
###xml 626 633 626 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">Table 1</xref>
###xml 724 732 724 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s008">Table S2</xref>
###xml 844 850 844 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g003">Fig. 3</xref>
###xml 852 859 852 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">Table 1</xref>
###xml 1044 1051 1044 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">Table 1</xref>
Because there was only one opportunity to assess DA tissue content along with TH protein and TH phosphorylation, we compared the locomotor activity results in five time-related measures; lifetime average (mean of 17 total locomotor trials conducted at 4 and 12 months for the young group and 22 and 30 months for the old group), session 2 (mean of seven locomotor trials conducted at 12 and 30 months), highest and lowest lifetime (highest ever, and lowest ever, locomotor activity measures of the 17 sessions), and last trial (the final locomotor activity measure of the 17, recorded immediately prior to tissue dissection) (Table 1). Total DA tissue content from the SN, but not striatum, NAc, or VTA (NAc and VTA data in Table S2), correlated significantly with four of five locomotor parameters, the notable exception being movement speed (Fig. 3, Table 1), and for each time-related comparison. Striatal DA did not correlate with any locomotor parameter, but there was a noted trend with the lifetime average and session 2 movement speed (Table 1). This lack of correlation may be related to the small insignificant aging-related loss of striatal or accumbal DA.
###end p 44
###begin title 45
Dopamine bioavailability and correlation to locomotor activity generation.
###end title 45
###begin p 46
###xml 180 181 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 257 258 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 267 290 267 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Movement number, a. str</bold>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 311 316 311 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b. SN</bold>
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 341 368 341 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Horizontal activity, c. str</bold>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 389 394 389 394 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d. SN</bold>
###xml 398 399 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 419 444 419 444 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Time spent moving, e. str</bold>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 465 470 465 470 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e. SN</bold>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 546 553 546 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">Table 1</xref>
Total DA in striatum ((str) a, c, e) versus substantia nigra ((SN) b, d, f) and correlation to mean lifetime locomotor activity measures in all 14 subjects, ages 12 and 30 months (n = 7 each age group). The following are the Spearman correlation values and p-values; Movement number, a. str, p = 0.65, r = 0.13 b. SN, **p = 0.008, r = 0.68, Horizontal activity, c. str, p = 0.58, r = 0.16 d. SN, **p = 0.008, r = 0.72; Time spent moving, e. str, p = 0.42, r = 0.24 e. SN, *p = 0.01, r = 0.64. Additional statistical correlations are presented in Table 1.
###end p 46
###begin title 47
3.3 Relative Individual Locomotor Activities Are Maintained but Decline with Aging
###end title 47
###begin p 48
###xml 199 208 199 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g004">Fig. 4a&#8211;c</xref>
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 424 425 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 552 553 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Consistent with the literature, significant aging-related decreases occurred in all locomotor measures with the exception of movement speed. Movement number, horizontal activity, time spent moving, (Fig. 4a-c), and total distance traveled (data not shown) decreased significantly between the age groups (ANOVA, p<0.0001). Importantly, there was a significant group difference between the two age groups at 12 and 30 months (p<0.05), the ages at which neurochemical profiles were obtained. There was a significant difference at 4 and 22 months as well (p<0.001, Bonferroni's multiple comparison test), broaching the possibility of an inherent molecular basis for locomotor activity. The significant group differences in locomotor activity, in addition to the variances seen within groups, gave a range of inherent differences in locomotor activity to address this possibility.
###end p 48
###begin title 49
Longitudinal-characterization of locomotor activity during aging.
###end title 49
###begin p 50
###xml 216 218 216 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a.</bold>
###xml 218 233 218 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">movement number</italic>
###xml 248 249 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 258 266 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 282 283 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 337 338 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 361 362 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 433 435 433 435 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b.</bold>
###xml 435 454 435 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">horizontal activity</italic>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 479 487 479 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 583 584 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 591 593 591 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.</bold>
###xml 593 610 593 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">time spent moving</italic>
###xml 625 626 625 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 635 643 635 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 660 661 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 715 716 715 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 739 740 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 747 761 747 761 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Data not shown</bold>
###xml 763 777 763 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">total distance</italic>
###xml 792 793 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 802 810 802 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 826 827 826 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 879 880 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 903 904 903 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 915 932 915 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">movement velocity</italic>
###xml 947 948 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 956 964 956 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 981 982 981 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1036 1037 1036 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1060 1061 1060 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Mean for the age tested represented by horizontal line and the locomotor activities of test subjects represented by points. The young group was tested at 4 and 12 months and the old group tested at 22 and 30 months. a.movement number (ANOVA, group p<0.0001; post-hoc 12 vs. 30 mos, p<0.05): aging difference within group, 4 vs. 12 mos., p<0.05; 22 vs. 30 mos., p<0.05 (Student's paired t-test used for all within group comparisons). b.horizontal activity (ANOVA, group p<0.0001; post-hoc 12 vs. 30 mos., p<0.01): aging difference within group, 4 vs. 12 mos., p<0.05; 22 vs. 30 mos., p<0.05. c.time spent moving (ANOVA, group p<0.0001; post-hoc 12 vs. 30 mos., p<0.05): aging difference within group, 4 vs. 12 mos., p<0.05; 22 vs. 30 mos., p<0.05. Data not shown: total distance (ANOVA, group p<0.0001; post-hoc 12 vs. 30 mos, p<0.05): age difference within group, 4 vs. 12 mos., p<0.05; 22 vs. 30 mos., p>0.05, and movement velocity (ANOVA, group p<0.005; post-hoc 12 vs. 30 mos., p>0.05): aging difference within group, 4 vs. 12 mos., p<0.05; 22 vs. 30 mos., p<0.05.
###end p 50
###begin p 51
###xml 64 70 64 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g004">Fig. 4</xref>
###xml 480 489 480 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g005">Fig. 5a&#8211;c</xref>
While there was an aging-related decline in locomotor activity (Fig. 4), individual test subjects had consistent locomotor activity levels in relation to the other test subjects between the eight months of locomotor trials, suggesting that there is a neurobiological basis for locomotion maintained with respect to the group, though declining, in each individual with advancing age. There was a significant correlation for movement number, horizontal activity, time spent moving (Fig. 5a-c), total distance and movement speed (data not shown) between the first and second test sessions. Thus comparisons of DA and TH measures to inherent lifetime locomotor patterns of test subjects could reveal how TH regulates DA bioavailability and inherent locomotor activity.
###end p 51
###begin title 52
Individual locomotor activities with respect to group throughout the life span.
###end title 52
###begin p 53
###xml 350 352 350 352 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a.</bold>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 391 393 391 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b.</bold>
###xml 421 422 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 444 446 444 446 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.</bold>
###xml 488 489 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 553 554 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 607 608 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 20 24 <span type="species:ncbi:10116">rats</span>
Young adult and old rats were tested at 4 and 22 months old, and again at 12 and 30 months old. There was a significant correlation in locomotor activity between the mean performance for each test subject at the first testing period (ten trial average) and second testing period (seven trial average) of locomotor activity tested eight months later: a. movement number, p<0.0001, r = 0.865; b. horizontal activity (HAC), p = 0.0001, r = 0.846; c. time spent moving (as seconds per hour), p<0.0001, r = 0.868. Data not shown are movement speed (cm/sec), p = 0.0001, r = 0.848, and distance traveled (cm/hr), p<0.0001, r = 0.881.
###end p 53
###begin title 54
3.4 Aging, Population Variance, and a Dopaminergic Basis
###end title 54
###begin p 55
###xml 302 308 302 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g006">Fig. 6</xref>
###xml 791 798 791 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s005">Fig. S4</xref>
###xml 1078 1085 1078 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Figs. 1</xref>
###xml 1087 1088 1087 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g002">2</xref>
###xml 5 9 <span type="species:ncbi:10116">rats</span>
Aged rats have an inherent decrease in locomotor activity and provide intact neuropil to compare where DA bioavailability affects locomotor activity measures. We found that DA levels were significantly lower only in the SN (36% decrease including outlier in 30-month group and 43% decrease without it (Fig. 6)). The levels of DA between the 12 and 30 month old groups trended lower in the striatum (15% decrease) and NAc (11% decrease), but, like those in VTA, were not significantly different. Of note, the nigral DA value in the outlier subject of the older group was at the 12-month mean (8.3 ng/mg protein) and this subject had the highest locomotor activity level of the group. Total DA levels (not normalized to total protein) in SN also decreased significantly in the 30 month group (Fig. S4). Therefore, the significant decrease in overall DA bioavailability occurring in the 30 month group only in the SN implies that ser31 phosphorylation is also decreased in aged SN, given the importance of ser31 phosphorylation in regulating DA bioavailability in intact neuropil (Figs. 1, 2).
###end p 55
###begin title 56
Aging and DA tissue content.
###end title 56
###begin p 57
###xml 138 140 138 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a.</bold>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">striatum</italic>
###xml 189 191 185 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b.</bold>
###xml 191 207 187 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">substantia nigra</italic>
###xml 211 212 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 256 258 248 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.</bold>
###xml 258 275 250 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nucleus accumbens</italic>
###xml 316 318 304 306 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d.</bold>
###xml 318 340 306 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ventral tegmental area</italic>
###xml 538 544 522 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s005">Fig S4</xref>
###xml 138 148 <span type="species:ncbi:225775|species:ncbi:60296|species:ncbi:131590">a.striatum</span>
Values are ng DA/ mg protein in 12- and 30-month old subjects in the nigrostriatal (a, b) and mesoaccumbens (c, d) dopaminergic pathways. a.striatum, ns, 12 mo.,178+/-17, 30 mo., 152+/-19, b.substantia nigra, **p<0.01, 12 mo., 7.6+/-0.5, 30 mo. 4.9+/-0.6, c.nucleus accumbens, ns, 12 mo., 83+/-6.9, 30 mo. 74+/-2.8, d.ventral tegmental area, ns, 12 mo., 9.0+/-1.5, 30 mo., 9.4+/-2.5. These statistical relationships (Student's t-test, unpaired) also held in the comparison of total DA recovery (not normalized to protein) in each region (Fig S4).
###end p 57
###begin title 58
3.5 The Role of TH in Locomotor Activity
###end title 58
###begin p 59
###xml 248 255 248 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Figs. 1</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g002">2</xref>
###xml 412 413 412 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 421 431 421 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g007">Fig. 7a, b</xref>
###xml 478 490 478 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">introduction</xref>
###xml 844 845 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 853 862 853 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g008">Fig. 8a,b</xref>
###xml 999 1000 999 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1091 1098 1091 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g006">Fig. 6b</xref>
Nigral TH protein content alone did not significantly correlate to locomotor activity measures (data not shown). This was not particularly surprising given the involvement of phosphorylation at ser31 in regulating bioavailability of DA in the CNS (Figs. 1, 2). There was a significant decrease in TH protein in the SN in the 30 month old group, when the previously mentioned outlier was removed from this group (p<0.05) (Fig. 7a, b), consistent with reports as discussed in the introduction. [The total TH protein in this subject accounted for significantly elevated DA levels, as ser31 phosphorylation in this subject was only 14% above the group mean.] No significant age-related loss of TH protein was seen in the other three regions (data not shown). There was also a 30% reduction in ser31 phosphorylation in the SN in the 30-month group (p<0.05) (Fig. 8a,b) and, as a result of the lower TH protein and ser31 phosphorylation, there was a 44% reduction in the effective stoichiometry of ser31 (p<0.05) (data not shown). This was identical to the actual decrease in DA levels in the SN (Fig. 6b). Other than a <20% reduction in ser19 phosphorylation in VTA and ser31 phosphorylation in the NAc, no other significant aging-related changes in phosphorylation were observed in the four brain regions (data not shown).
###end p 59
###begin title 60
Nigral TH protein loss in aging.
###end title 60
###begin p 61
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a.</bold>
###xml 441 443 425 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b.</bold>
###xml 585 586 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 119 122 <span type="species:ncbi:10116">rat</span>
a. Representative blot showing the approximately40% decrease in total TH (tTH) protein in the SN in a 30-month old BNF rat compared to the tTH content in the 12-month old. All TH protein assays are conducted against a standard curve with quantified TH protein. A specific quantity of total protein is loaded from the sample to determine the ng tTH per microg protein and the quantity from the sample is interpolated from the standard curve. b. nigral total TH protein content between the 12- and 30-mo old subjects, 0.053+/-0.010 and 0.028+/-0.005 ng per microg protein, respectively. p<0.05 (Student's t-test, unpaired).
###end p 61
###begin title 62
Nigral TH phosphorylation stoichiometry in aging.
###end title 62
###begin p 63
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a.</bold>
###xml 978 980 962 964 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b.</bold>
###xml 1117 1118 1101 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 103 106 <span type="species:ncbi:10116">rat</span>
a. Representative blot showing the 30% decrease in TH phosphorylation at ser31 in the 30-month old BNF rat. All TH phosphorylation assays are conducted against a standard curve with quantified site-specific phosphorylation levels so actual quantities of phosphorylated TH at each phosphorylation site are loaded in the standard curve range and the quantity of phosphorylated TH from the sample is interpolated from the standard curve. Because actual quantities of total TH (tTH) vary from sample-to-sample, it is not always possible to load equal amounts of tTH. Total protein load among samples is kept within 25 microg if at all possible to keep any carrier protein effects upon the signal to an absolute minimum. In this case, total protein load differed by 10 microg (80 microg for the 12 mo sample and 90 microg for the 30 mo sample). The standard curve source is from a calibrated PC12 cell extract with a phosphorylation stoichiometry at ser31 at 0.09 ng p31 per ng tTH. b. Site-specific phosphorylation of TH in the SN in test subjects. The 30-month group had significantly reduced phosphorylation at ser 31 (p = 0.029, unpaired Student's t-test). No significant change was observed at ser40 or ser19.
###end p 63
###begin p 64
###xml 88 94 88 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g003">Fig. 3</xref>
###xml 184 191 184 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Figs. 1</xref>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g002">2</xref>
###xml 418 425 418 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">Table 1</xref>
###xml 822 828 822 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g009">Fig. 9</xref>
Given the relationship established between nigral DA and open-field locomotor activity (Fig. 3) as well as the role of ser31 effective stoichiometry in determining DA bioavailability (Figs. 1, 2), ser31 TH phosphorylation in SN would be predicted to correlate to inherent locomotor activity. Indeed, ser31 phosphorylation was correlated to the same locomotor activity measures as total DA or DA normalized to protein (Table 1), with the only exceptions being lowest lifetime total distance and lowest time spent moving measures. Our longitudinal characterization of locomotor activity enabled us to determine how effective stoichiometry of ser31 in SN affected locomotor capabilities. There was a significant correlation with the highest ever recorded lifetime movement number, horizontal activity, and time spent moving (Fig. 9). Therefore, nigral ser31 TH phosphorylation may regulate inherent abilities to generate locomotor activity.
###end p 64
###begin title 65
Effective stoichiometry at ser31 and locomotor activity.
###end title 65
###begin p 66
###xml 325 344 325 344 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">movement number (a)</bold>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 366 389 366 389 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">horizontal activity (b)</bold>
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 410 431 410 431 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">time spent moving (c)</bold>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Effective stoichiometry of ser31 (the product of ser31 phosphorylation stoichiometry and TH protein quantity) correlates with the highest ever recorded locomotor activity measures (movement number, horizontal activity, and time spent moving) of the 17 trials for each test subject. Spearman correlation stats are as follows; movement number (a), r = 0.59, p = 0.03, horizontal activity (b), r = 0.65, p = .01, time spent moving (c), r = 0.57, p = 0.03.
###end p 66
###begin title 67
Discussion
###end title 67
###begin p 68
###xml 63 67 63 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Cheramy1">[34]</xref>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Andersson1">[39]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Trevitt1">[41]</xref>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Kliem1">[59]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Thompson1">[60]</xref>
###xml 1348 1352 1348 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Palmiter1">[31]</xref>
###xml 1353 1357 1353 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Huang1">[32]</xref>
###xml 1359 1363 1359 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Freed1">[61]</xref>
###xml 242 247 <span type="species:ncbi:10090">mouse</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 588 592 <span type="species:ncbi:10116">rats</span>
Somatodendritic release of nigral DA has been long established [34] and its pharmacological manipulation modulates locomotor-regulating functions of the basal ganglia and aspects of locomotion [39]-[41], [59]. Furthermore, transplantation of mouse fetal midbrain cells into the SN, rather than the striatum, of 6-OHDA-lesioned adult mice may have a greater restorative capacity to locomotor function [60]. Nonetheless, it has been questioned as to whether such manipulations could somehow coincidentally modulate striatal functions. Here we show, using intact and pharmacologically-naive rats with inherent differences in locomotor activity, that locomotor activity generation capacities in an open-field correlate to nigral, but not striatal, DA tissue content. Furthermore, the aging-related loss of DA in the SN, rather than striatum, in conjunction with a significant decline in locomotor activity in the 30-month group supports a role for nigral DA tissue content in modulating locomotor activity generation. We note that movement speed was not correlated with nigral DA tissue content and was also not significantly different between the 12 and 30 month old subjects, suggesting this component of locomotor activity is not influenced by nigral DA content. Striatal and accumbal DA content do affect motivational aspects of locomotor activity [31]-[32], [61]. However, the lack of significant DA loss in striatum or nucleus accumbens between the age groups may have accounted for why there was not a significant correlation in these regions with locomotor speed.
###end p 68
###begin p 69
###xml 141 145 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Kish1">[11]</xref>
###xml 146 150 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Haycock1">[15]</xref>
###xml 152 156 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Irwin1">[17]</xref>
###xml 158 162 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Ponzio1">[44]</xref>
###xml 164 168 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-CruzMuros1">[54]</xref>
###xml 170 174 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Marshall1">[62]</xref>
###xml 175 179 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Collier1">[65]</xref>
###xml 528 532 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Bezard1">[10]</xref>
###xml 776 780 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Yurek1">[13]</xref>
###xml 782 786 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Irwin1">[17]</xref>
###xml 788 792 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Ponzio1">[44]</xref>
###xml 898 904 874 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g007">Fig. 7</xref>
###xml 956 960 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Bezard1">[10]</xref>
###xml 986 990 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Fearnley1">[42]</xref>
###xml 968 973 <span type="species:ncbi:9606">human</span>
###xml 977 985 <span type="species:ncbi:9606">patients</span>
Well-executed aging studies that quantify striatal DA show varying amounts of tissue DA loss with age, ranging from 0 up to approximately50% [11]-[15], [17], [44], [54], [62]-[65]. However, if the widely-accepted threshold of 70-80% loss of DA neuropil is necessary for appearance of PD motor symptoms (such as bradykinesia), we must consider then how the lesser (if any in some cases) loss of striatal DA in aging still precipitates bradykinesia. In PD models, PD-like symptoms are not observed with 42-58% loss of striatal DA [10]. It is possible that striatal DA is critical for aspects of locomotor activity not related to initiating locomotor activity, such as movement speed. However, the loss of nigral DA seen in our work has also been reported in other aging studies [13], [17], [44]. Furthermore, loss of nigral TH protein of approximately40%, as seen in the 30-month group in our study (Fig. 7), is coincident with PD-like symptoms in PD models [10] and in human PD patients [42]. These observations in conjunction with our findings, which are coincident measures of both striatal and nigral DA that are associated with longitudinally-characterized locomotor activity, make a case that nigral DA has a role in modulating basal ganglia circuitry to facilitate the generation of locomotor activity.
###end p 69
###begin p 70
###xml 341 353 341 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1, a, b</xref>
###xml 614 620 614 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g001">Fig. 1</xref>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g002">2</xref>
###xml 973 980 973 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1101 1105 1101 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Waymire1">[24]</xref>
###xml 1106 1110 1106 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Dunkley1">[26]</xref>
###xml 1285 1289 1285 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore3">[27]</xref>
###xml 1291 1295 1291 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Conner1">[28]</xref>
###xml 1536 1542 1536 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g009">Fig. 9</xref>
###xml 1802 1806 1802 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Collier1">[65]</xref>
###xml 1808 1812 1808 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Cass1">[66]</xref>
###xml 89 93 <span type="species:ncbi:10116">rats</span>
Given that both the locomotor activity and DA and TH analyses were conducted in the same rats, a critical importance for phosphorylation at ser31 in regulating DA tissue content and a DA-dependent behavior (locomotion) was revealed. First, the differences in DA tissue content across the four regions did not correspond to total TH protein (Fig. 1, a, b). However, in conjunction with TH protein content, phosphorylation at ser31, but not ser19 or ser40, showed significant differences between striatum, SN, nucleus accumbens, and VTA that reflected the inherent differences in DA tissue content in these regions (Fig. 1, 2). The other major indication that ser31 phosphorylation affected DA bioavailability is that the significant loss of DA (along with TH protein loss) in the SN in the aged subjects was associated with a significant decrease in phosphorylation only at ser31. Together, these observations address which TH phosphorylation site regulates DA biosynthesis in vivo in intact neuropil: a vital question yet to be answered. However, phosphorylation at ser40 can increase DA biosynthesis [24]-[26]. It may that challenges to DA systems such as that in neurodegenerative processes could increase ser40 phosphorylation to an extent that affects DA biosynthesis capabilities [27], [28]. Still, in intact and drug-naive DA pathways, ser31 phosphorylation and TH protein levels appear to regulate basal DA bioavailability. In the SN, these mechanisms may define the maximal locomotor capabilities inherent to our test subjects (Fig. 9). Determining whether ser31 or ser40 regulate DA biosynthesis in the TH-depleted SN in a PD model is an important next step, particularly since aging may impair compensatory processes that normally replenish DA in the face of TH loss seen in PD and PD models [65], [66].
###end p 70
###begin p 71
###xml 300 307 300 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s006">Fig. S5</xref>
###xml 368 370 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1159 1166 1159 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">Table 1</xref>
###xml 1585 1592 1585 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s006">Fig. S5</xref>
###xml 2046 2050 2046 2050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Ossowska1">[67]</xref>
###xml 1847 1850 <span type="species:ncbi:10116">rat</span>
###xml 1918 1921 <span type="species:ncbi:10116">rat</span>
Our assessment of locomotion took into account that the neurochemical profile attained for each test subject was only a one-time measure. In spite of definite differences in average locomotor activity shown in the test subjects, the test subjects had variable locomotor activity from trial to trial (Fig. S5). Therefore, a correlation of DA bioavailability with the 17th and final trial was essential. On one hand, this correlation might be expected to be the most relevant one because the DA levels inherent in the test subject were temporally matched with the locomotor activity observed. On the other hand, indeterminate factors could also influence locomotion on a trial to trial basis, such as the subject's level of arousal, motivation for food or drink, or circadian type fluctuations that might occur within the 8 hour time window (0900 to 1700) we did our testing. Therefore, average locomotor activity results would attenuate the influence of these indeterminate effects. We found significant correlations with nigral DA content for all comparisons to movement number, horizontal activity, and time spent moving when accounting for these variables (Table 1). It is also possible that trial-by-trial variances in locomotor activity could be related to variances in DA bioavailability, which, like locomotor activity, could fluctuate around a mean value. We also point out that in the minority of observations in the 17 trials, there were some matched test subjects that, in spite of having significant differences in mean activity, had on occasion similar locomotor activity (Fig. S5). This observation suggests that other aging-related issues such as muscle function likely did not contribute to the aging-related decline of locomotor activity generation. For if aging-related muscle dysfunction did affect movement generation, an older rat would presumably never generate movement akin to that of a younger rat. The lack of correlation of central DA systems with aging-related muscle function decline has also been previously reported [67].
###end p 71
###begin p 72
###xml 70 73 70 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Fleischman1">[3]</xref>
###xml 75 78 75 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Murray1">[4]</xref>
###xml 168 171 168 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Murray1">[4]</xref>
###xml 554 560 554 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g005">Fig. 5</xref>
###xml 755 761 755 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g004">Fig. 4</xref>
###xml 915 921 915 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g006">Fig. 6</xref>
###xml 806 809 <span type="species:ncbi:10116">rat</span>
###xml 877 880 <span type="species:ncbi:10116">rat</span>
###xml 910 913 <span type="species:ncbi:10116">rat</span>
Aging brings an inherent risk of developing Parkinson's-like symptoms [3], [4], and their incidence increases dramatically from 15% of those at age 65 to 52% at age 85 [4]. This suggests that aging-related bradykinesia may not be universal, but the incidence certainly increases with advancing age. The neurobiological basis for the occurrence is not well understood. In our study, it appears that activity levels, which may ultimately be related to nigral ser31 and TH protein levels, at a younger age dictate the locomotor activity with advancing age (Fig. 5). There was a significant decrease in locomotor activity parameters that correlated with nigral DA (movement number, horizontal activity, and time spent moving) between 22 and 30 months of age (Fig. 4). We did not measure DA in the 22-month old rat, but there was a significant decrease in nigral DA in the 30-month rat compared to the 12-month old rat (Fig. 6). Based upon the locomotor data and the two time points at 12 and 30 months wherein DA was measured, we would predict that nigral DA loss would be less overall at 22 months than at 30 months. Taken together, these data imply that the likelihood bradykinesia occurring with aging may depend upon activity levels at a younger age, and nigral ser31 phosphorylation and TH protein levels could play a role in the inherent risk of developing aging-related Parkinsonism.
###end p 72
###begin p 73
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Hebert1">[12]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Gerhardt1">[14]</xref>
###xml 244 248 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Gerhardt1">[14]</xref>
###xml 541 545 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Andersson1">[39]</xref>
###xml 1072 1078 1036 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g003">Fig. 3</xref>
###xml 1080 1087 1044 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">Table 1</xref>
###xml 923 926 <span type="species:ncbi:10116">rat</span>
In spite of little or no loss of striatal DA tissue content in the aged test subjects, deficient DA release in aged striatum [12], [14], could impact locomotor activity. However, release capacity of nigral DA also decreases to approximately70% [14]. Therefore, both regions show diminished DA release capacity with aging. Thus the contribution of diminished DA release in either region to aging-related bradykinesia is not known. However, pharmacological blockade of nigral DA release to the extent seen in aging reduces rotorod performance [39], which suggests sufficient nigral DA bioavailability is necessary for enabling movements required to negotiate motor tasks. We show nigral DA content in the 30-month old group was approximately4.3 ng/mg protein or 6.6 ng of total nigral DA in the rostral-caudal extension and this was associated with significant reduction in locomotor activity relative to adult, 12-month old rat, which had approximately7.6 ng/mg protein or 10.3 ng total nigral DA. The significant correlation of nigral DA with locomotor activity measures (Fig. 3, Table 1) and aging-related reductions in nigral DA both make a case that nigral DA bioavailability is involved with the generation of locomotor activity.
###end p 73
###begin p 74
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Parkinson1">[30]</xref>
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Freed1">[61]</xref>
###xml 313 320 313 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">Table 1</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Palmiter1">[31]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Freed1">[61]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Everitt1">[68]</xref>
###xml 815 821 815 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g006">Fig. 6</xref>
###xml 1160 1164 1160 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Brown1">[69]</xref>
Striatal or accumbal DA content could influence aspects of locomotion not related to its initiation and maintenance, such as movement speed [30], [61]. Notably, movement speed was not significantly different between the two age groups and did not correlate to nigral DA as did the other four parameters measured (Table 1). Thus, movement speed may be independent of the ability to initiate locomotor activity and is likely to be associated with DA signaling in striatum or nucleus accumbens, wherein DA signaling has been linked to motivational states [31], [61], [68]. We did note a trend toward significance with lifetime and second session average movement speed correlating to total striatal DA recovered. Therefore, experimental manipulation of DA in these regions beyond that produced by aging in this study (Fig. 6) could reveal a role for DA in locomotor parameters affected in PD (wherein such major loss is seen) such as movement speed, balance, gait function, and tremor at rest. It must be noted, however, that the inherent ability to generate movement, or readiness, is likely to be associated with DA bioavailability of the nigrostriatal pathway [69]. Our data suggest that nigral DA bioavailability is a significant neurobiological component in inherent abilities to initiate volitional movement.
###end p 74
###begin p 75
###xml 967 974 967 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1087 1094 1087 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1094 1098 1094 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Salvatore3">[27]</xref>
###xml 1100 1104 1100 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008466-Conner1">[28]</xref>
###xml 1391 1398 1391 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 96 100 <span type="species:ncbi:10116">rats</span>
In summary, longitudinally-characterized locomotor activity patterns of pharmacologically-naive rats with intact nigrostriatal and mesoaccumbens pathways showed that nigral DA bioavailability, as regulated by TH protein and phosphorylation at ser31, influenced inherent capacities for the initiation and maintenance of locomotor activity. Reduced nigral, but not striatal, DA was associated with aging-related bradykinesia. We do not imply that striatal or accumbal DA has no influence upon locomotor activity, but it may be that experimental manipulation of DA levels exceeding that seen in this study (15% or less DA loss) may be necessary to determine how DA in these regions affects other locomotor parameters. We also show that in intact dopaminergic neuropil, the phosphorylation of TH at ser31, but not ser40, in addition to TH protein, governs DA bioavailability. This is not to say that ser40 phosphorylation could not influence DA biosynthesis capabilities in vivo, as certain pathologies or conditions might increase ser40 levels sufficiently enough to impact DA biosynthesis in vivo[27], [28]. However, TH protein and phosphorylation at ser31 in the SN was significantly correlated with DA tissue content and with locomotor activity levels. Therefore, studies wherein the regulation of the biosynthesis of DA or other catecholamines, like norepinephrine, is called into question in vivo must include analysis of ser31 phosphorylation dynamics. Future studies should address the extent to which changes in ser31 and ser40 phosphorylation, induced via experimental manipulation, affect DA biosynthesis capacity in the regions studied herein. Furthermore, modulation of DA bioavailability through inhibition or augmentation of levels in striatum and SN would determine the extent to which DA in each region modulates particular aspects of locomotor activity. In a larger realm, these results also suggest that focusing on neurotransmitter function solely at terminal fields is insufficient to understand behavior. Clearly, regulation of neurotransmitter function in somatodendritic regions must be considered as well.
###end p 75
###begin title 76
Supporting Information
###end title 76
###begin p 77
Critical supporting information for manuscript.
###end p 77
###begin p 78
(0.03 MB DOC)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
Phosphorylation-state specificity of ser31 antibody produced by 21st Century Biochemicals. Top row values are the quantity of total TH assayed to generate the phosphorylation-state specific immunoreactivity quantities for the ser31 phosphorylation site on TH (as listed in the bottom row). The relative stoichiometries of ser31 phosphorylation for the two sources used were 0.8 for the group of three standards on the left (lanes 1-3) and 0.09 for the group of three standards on the right (lanes 4-6).
###end p 80
###begin p 81
(0.04 MB TIF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
Correlation of total TH versus total DA in the substantia nigra (SN). Spearman r = 0.656, p = 0.011. All data points represent operationally-matched results from SN dissections from the subjects used in this locomotor correlation study.
###end p 83
###begin p 84
(0.01 MB TIF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
Correlation of movement number with other locomotor activity parameters. Data presented are means of individual locomotor tests conducted at 4 and 22 months and movement number correlated to horizontal activity (HAC) (p<0.0001; r = 0.982), total distance (cm/hr) (p<0.0001; r = 0.947), and time spent moving (p<0.0001; r = 0.937). No significant correlation of movement number to movement speed (movt velocity) (p = 0.065) was seen. Significant correlations were also observed at 12 and 30 months of age for HAC, total distance, and time spent moving.
###end p 86
###begin p 87
(0.01 MB TIF)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
###xml 81 89 81 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008466-g005">Figure 5</xref>
###xml 417 424 417 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008466-t001">Table 1</xref>
###xml 442 450 442 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008466.s008">Table S2</xref>
Dopamine content (expressed as total harvested in the dissections) in the SN. In Figure 5 in the main text, DA content is normalized to total protein. This figure shows that total DA tissue content is reduced in the 30 month group, overall. Note there is considerable overlap in nigral DA content between the two groups, and the DA levels from each of these subjects were compared to locomotor parameters, as seen in Table 1 in main text and Table S2. Overall levels were 10.30+/-0.96 ng in the 12-mo group and 6.6+/-1.0 ng in the 30-mo group. Statistics, Unpaired Student t-test p<0.05.
###end p 89
###begin p 90
(0.01 MB TIF)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
Example of between-group differences and session-to-session variability total distance and movement number in two selected pairs of young and old test subjects. Test results are from the 12 and 30 month session. In young-1 vs. old-1, no difference in mean locomotor activity was seen in spite of the age difference, whereas in young-2 vs. old-2 a significant difference in mean locomotor activity is evident. This exception to the overall difference in locomotion with aging we report highlights that aging is not necessarily associated with bradykinesia on a case-by-case basis. Furthermore it is evident that young-1 would be at the low end of activity level for that age-group, when compared to activity seen in young-2. Also noted in the young-2 versus old-2 comparison is that in order to fully characterize locomotor activity, multiple sessions are necessary. For example, if comparing session results from the young subject that were at the low end of the locomotor activity range versus session results from the old subject at the high end of the range, as highlighted by the box-inset, little difference in locomotor activity between the subjects would be concluded.
###end p 92
###begin p 93
(0.01 MB TIF)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
Habituation of locomotion.
###end p 95
###begin p 96
(0.04 MB DOC)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
Mesoaccumbens pathway DA correlations (p-values).
###end p 98
###begin p 99
(0.05 MB DOC)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
###xml 70 77 <span type="species:ncbi:15957">Timothy</span>
We thank Drs. Trevor W. Robbins, Richard Zweig, Donald K. Ingram, and Timothy J. Collier for critical review and discussion.
###end p 101
###begin title 102
References
###end title 102
###begin article-title 103
###xml 93 99 <span type="species:ncbi:9606">people</span>
Prevalence of Parkinsonian signs and associated mortality in a community population of older people.
###end article-title 103
###begin article-title 104
###xml 51 57 <span type="species:ncbi:9606">people</span>
Extrapyramidal signs in cognitively intact elderly people.
###end article-title 104
###begin article-title 105
Parkinsonian signs and functional disability in old age.
###end article-title 105
###begin article-title 106
###xml 87 93 <span type="species:ncbi:9606">people</span>
A longitudinal study of Parkinsonism and disability in a community population of older people.
###end article-title 106
###begin article-title 107
Association between late-life social activity and motor decline in older adults.
###end article-title 107
###begin article-title 108
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
###end article-title 108
###begin article-title 109
###xml 60 63 <span type="species:ncbi:10116">rat</span>
Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.
###end article-title 109
###begin article-title 110
Biochemical pathophysiology of Parkinson's disease.
###end article-title 110
###begin article-title 111
###xml 138 142 <span type="species:ncbi:10116">rats</span>
Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6- hydroxydopamine lesioned rats.
###end article-title 111
###begin article-title 112
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-lesioned Macaque model of Parkinson's disease.
###end article-title 112
###begin article-title 113
Aging produces a specific pattern of striatal dopamine loss: Implications for the etiology of idiopathic Parkinson's disease.
###end article-title 113
###begin article-title 114
###xml 119 123 <span type="species:ncbi:10116">rats</span>
Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in Fischer 344 rats.
###end article-title 114
###begin article-title 115
###xml 105 109 <span type="species:ncbi:10116">rats</span>
Age-related decline in striatal dopamine release and motoric function in Brown Norway/Fischer 344 hybrid rats.
###end article-title 115
###begin article-title 116
###xml 72 86 <span type="species:ncbi:9544">rhesus monkeys</span>
Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys.
###end article-title 116
###begin article-title 117
###xml 103 108 <span type="species:ncbi:9606">human</span>
Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.
###end article-title 117
###begin article-title 118
###xml 111 116 <span type="species:ncbi:9606">human</span>
Effect of aging on tyrosine hydroxylase protein content and the relative number of dopamine nerve terminals in human caudate.
###end article-title 118
###begin article-title 119
###xml 51 56 <span type="species:ncbi:9606">human</span>
Aging and the nigrostriatal dopamine system: a non-human primate study.
###end article-title 119
###begin article-title 120
###xml 136 141 <span type="species:ncbi:9606">human</span>
Kubis N, Faucheux BA, Ransmayr G, Damier P, Duyckaerts C, et al. ( 2000) Preservation of midbrain catecholaminergic neurons in very old human subjects.
###end article-title 120
###begin article-title 121
Decreased plasma membrane expression of striatal dopamine transporter in aging.
###end article-title 121
###begin article-title 122
Aging of the nigrostriatal system in the Squirrel monkey.
###end article-title 122
###begin article-title 123
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 24 27 <span type="species:ncbi:10116">rat</span>
Tyrosine hydroxylase in rat brain dopaminergic nerve terminals: Multiple-site phosphorylation in vivo and in synaptosomes.
###end article-title 123
###begin article-title 124
Role of Serine-19 phosphorylation in regulating tyrosine hydroxylase studied with site- and phosphospecific antibodies and site-directed mutagenesis.
###end article-title 124
###begin article-title 125
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J. Biol. Chem.
###end article-title 125
###begin article-title 126
Vasoactive intestinal peptide stimulates catecholamine biosynthesis in isolated adrenal chromaffin cells: Evidence for a cyclic AMP-dependent phosphorylation and activation of tyrosine hydroxylase.
###end article-title 126
###begin article-title 127
###xml 132 139 132 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ.
###end article-title 127
###begin article-title 128
Tyrosine hydroxylase phosphorylation: regulation and consequences.
###end article-title 128
###begin article-title 129
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice.
###end article-title 129
###begin article-title 130
Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.
###end article-title 130
###begin article-title 131
Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme.
###end article-title 131
###begin article-title 132
Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine.
###end article-title 132
###begin article-title 133
Dopamine signaling in the dorsal striatum is essential for motivated behaviors.
###end article-title 133
###begin article-title 134
###xml 106 110 <span type="species:ncbi:10116">rats</span>
Effects of age on dopamine release in the nucleus accumbens and amphetamine-induced locomotor activity in rats.
###end article-title 134
###begin article-title 135
###xml 54 58 <span type="species:ncbi:10090">Mice</span>
Loss of Cocaine Locomotor Response in Pitx3-Deficient Mice Lacking a Nigrostriatal Pathway.
###end article-title 135
###begin article-title 136
Dendritic release of dopamine in the substantia nigra.
###end article-title 136
###begin article-title 137
Basal somatodendritic dopamine release requires snare proteins.
###end article-title 137
###begin article-title 138
Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices.
###end article-title 138
###begin article-title 139
Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway.
###end article-title 139
###begin article-title 140
###xml 85 99 <span type="species:ncbi:9544">rhesus monkeys</span>
Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys.
###end article-title 140
###begin article-title 141
Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
###end article-title 141
###begin article-title 142
Evidence that L-DOPA-induced rotational behavior is dependent on both striatal and nigral mechanisms.
###end article-title 142
###begin article-title 143
###xml 127 130 <span type="species:ncbi:10116">rat</span>
Substantia nigra pars reticulate is a highly potent site of action for the behavioral effects of the D1 antagonist SCH23390 in rat.
###end article-title 143
###begin article-title 144
Ageing and Parkinson's disease: Substantia nigra regional selectivity.
###end article-title 144
###begin article-title 145
###xml 74 78 <span type="species:ncbi:10116">rats</span>
Dopaminergic mesencephalic systems and behavioral performance in very old rats.
###end article-title 145
###begin article-title 146
###xml 80 84 <span type="species:ncbi:10116">rats</span>
Changes in monoamines and their metabolite levels in some brain regions of aged rats.
###end article-title 146
###begin article-title 147
###xml 19 24 <span type="species:ncbi:9606">human</span>
Morphometry of the human substantia nigra in ageing and Parkinson's disease.
###end article-title 147
###begin article-title 148
Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo.
###end article-title 148
###begin article-title 149
Functional recovery in parkinsonian monkeys treated with GDNF.
###end article-title 149
###begin article-title 150
###xml 134 138 <span type="species:ncbi:10116">rats</span>
Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats.
###end article-title 150
###begin article-title 151
###xml 111 125 <span type="species:ncbi:9544">Rhesus monkeys</span>
Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged Rhesus monkeys.
###end article-title 151
###begin article-title 152
###xml 79 82 <span type="species:ncbi:10116">rat</span>
Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in rat striatum and substantia nigra.
###end article-title 152
###begin article-title 153
###xml 101 104 <span type="species:ncbi:10116">rat</span>
Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.
###end article-title 153
###begin article-title 154
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputamenal infusion of glial cell line-derived neurotrophic factor.
###end article-title 154
###begin article-title 155
###xml 61 71 <span type="species:ncbi:10116">Norway rat</span>
Behavioral assessment of aging in male Fischer 344 and Brown-Norway rat strains and their F1 hybrid.
###end article-title 155
###begin article-title 156
###xml 13 16 <span type="species:ncbi:10116">rat</span>
Aging of the rat mesostriatal system: Differences between the nigrostriatal and the mesolimbic compartments.
###end article-title 156
###begin article-title 157
###xml 27 32 <span type="species:ncbi:9606">human</span>
Selecting animal models of human aging: Inbred strains often exhibit less biological uniformity than F1 hybrids.
###end article-title 157
###begin article-title 158
###xml 26 29 <span type="species:ncbi:10116">rat</span>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Current inbred and hybrid rat and mouse models.
###end article-title 158
###begin article-title 159
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo.
###end article-title 159
###begin article-title 160
###xml 119 123 <span type="species:ncbi:10116">rats</span>
Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis.
###end article-title 160
###begin article-title 161
Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys.
###end article-title 161
###begin article-title 162
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain.
###end article-title 162
###begin article-title 163
Regional brain dopamine metabolism: a marker for the speed, direction, and posture of moving animals.
###end article-title 163
###begin article-title 164
###xml 23 26 <span type="species:ncbi:10116">rat</span>
Age-related decline in rat striatal dopamine metabolism is regionally homogeneous.
###end article-title 164
###begin article-title 165
###xml 19 23 <span type="species:ncbi:10116">rats</span>
Locomotion of aged rats: Relationship to neurochemical but not morphological changes in nigrostriatal dopaminergic neurons.
###end article-title 165
###begin article-title 166
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Oxidative DNA damage in the aging mouse brain.
###end article-title 166
###begin article-title 167
Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism.
###end article-title 167
###begin article-title 168
###xml 86 90 <span type="species:ncbi:10116">rats</span>
Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats.
###end article-title 168
###begin article-title 169
Decline in motor functions in aging is related to the loss of NMDA receptors.
###end article-title 169
###begin article-title 170
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion.
###end article-title 170
###begin article-title 171
###xml 100 103 <span type="species:ncbi:10116">rat</span>
Simple and choice reaction time performance following unilateral striatal dopamine depletion in the rat: Impaired motor readiness but preserved response preparation.
###end article-title 171
###begin p 172
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 172
###begin p 173
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by a grant award to Michael F. Salvatore by the American Federation for Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 173

